T1	p 43 66	myocardial infarction ]
T2	p 128 138	infarction
T3	p 227 269	patients on thrombolytic therapy ( TLT ) .
T4	p 291 448	106 males with Q-MI entered the study . 47 received treatment without TLT and neoton , 30 patients received TLT with streptokinase preparations , 29 patients
T5	p 491 497	neoton
T6	i 8 39	Neoton and thrombolytic therapy
T7	i 239 267	thrombolytic therapy ( TLT )
T8	i 343 380	treatment without TLT and neoton , 30
T9	i 390 525	received TLT with streptokinase preparations , 29 patients were given streptokinase preparations and neoton . Left ventricular systolic
T10	i 551 567	echocardiography
T11	i 631 637	Holter
T12	i 667 669	MI
T13	i 1019 1031	Neoton given
T14	i 1035 1037	MI
T15	i 1047 1069	receiving TLT prevents
T16	o 149 166	systolic function
T17	o 500 534	Left ventricular systolic function
T18	o 694 741	arrest progression of left ventricular dilation
T19	o 760 773	hospital stay
T20	o 847 880	systolic and diastolic volumes of
T21	o 885 899	left ventricle
T22	o 1085 1122	left ventricular systolic dysfunction